Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Aleksandra Klisic MD, PhD"'
Autor:
Rosaria Vincenza Giglio BD, PhD, Emir M. Muzurović MD, PhD, Angelo Maria Patti MD, PhD, Peter P. Toth MD, PhD, Manyoo A. Agarwal MD, Wael Almahmeed MD, Aleksandra Klisic MD, PhD, Marcello Ciaccio MD, PhD, Manfredi Rizzo MD, PhD
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics, Vol 28 (2023)
Background: Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) are low-density lipoprotein cholesterol (LDL-C)-lowering drugs that play a critical role in lipoprotein clearance and metabolism. PCSK9i are used in patients with familial
Externí odkaz:
https://doaj.org/article/faa1eeb0bb4341d0aad3475c053e45d6